Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE

Dooley, Ma; Houssiau, Frédéric; Aranow, C; D'Cruz, Dp; Askanase, A; Roth, DA; Zhong, Zj; Cooper, S; Freimuth, Ww; Ginzler, Em

doi:10.1177/0961203312465781

Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE

Dooley, Ma

;

Houssiau, Frédéric

;

Aranow, C

;

D'Cruz, Dp

;

Ginzler, Em

;et.al.

(2013) Lupus — Vol. 22, n° 1, p. 63-72 (2013)

Files

pdfdocument.pdf

Restricted Access
Adobe PDF
476.94 KB

Request a copy

Details

Authors

Dooley, Ma
Author
Houssiau, FrédéricUCLouvain
Author
Aranow, C
Author
D'Cruz, Dp
Author
Ginzler, Em
Author

Affiliations

UCLouvainSSS/IREC/RUMA - Pôle de Pathologies rhumatismales
UCLouvain(SLuc) Service de rhumatologie

Citations

APA
Chicago
FWB

Dooley, M., Houssiau, F., Aranow, C., D’Cruz, D., Askanase, A., Roth, D., Zhong, Z., Cooper, S., Freimuth, W., & Ginzler, E. (2013). Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE. Lupus, 22(1), 63-72. https://doi.org/10.1177/0961203312465781 (Original work published 2013)